UK regulator looking into $39b AstraZeneca-Alexion deal
GBNEWS24 DESK//
Britain's competition regulator is reviewing AstraZeneca's $39 billion buyout of US-based Alexion on concerns it could reduce competition in the UK market or elsewhere.
The UK's Competition and Markets Authority…